Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA.
Resource URI: https://dblp.l3s.de/d2r/resource/publications/journals/bmcbi/WuILZHTZYXMGTF19
Home
|
Example Publications
Property
Value
dcterms:
bibliographicCitation
<
http://dblp.uni-trier.de/rec/bibtex/journals/bmcbi/WuILZHTZYXMGTF19
>
dc:
creator
<
https://dblp.l3s.de/d2r/resource/authors/Anna_Zhao-Wong
>
dc:
creator
<
https://dblp.l3s.de/d2r/resource/authors/Darshan_Mehta
>
dc:
creator
<
https://dblp.l3s.de/d2r/resource/authors/Guangxu_Zhou
>
dc:
creator
<
https://dblp.l3s.de/d2r/resource/authors/Hong_Fang
>
dc:
creator
<
https://dblp.l3s.de/d2r/resource/authors/Joshua_Xu
>
dc:
creator
<
https://dblp.l3s.de/d2r/resource/authors/Junshuang_Yang
>
dc:
creator
<
https://dblp.l3s.de/d2r/resource/authors/Leihong_Wu
>
dc:
creator
<
https://dblp.l3s.de/d2r/resource/authors/Shraddha_Thakkar
>
dc:
creator
<
https://dblp.l3s.de/d2r/resource/authors/Stephen_C._Harris
>
dc:
creator
<
https://dblp.l3s.de/d2r/resource/authors/Taylor_Ingle
>
dc:
creator
<
https://dblp.l3s.de/d2r/resource/authors/Weida_Tong
>
dc:
creator
<
https://dblp.l3s.de/d2r/resource/authors/Weigong_Ge
>
dc:
creator
<
https://dblp.l3s.de/d2r/resource/authors/Zhichao_Liu
>
foaf:
homepage
<
http://dx.doi.org/doi.org%2F10.1186%2Fs12859-019-2628-5
>
foaf:
homepage
<
https://doi.org/10.1186/s12859-019-2628-5
>
dc:
identifier
DBLP journals/bmcbi/WuILZHTZYXMGTF19
(xsd:string)
dc:
identifier
DOI doi.org%2F10.1186%2Fs12859-019-2628-5
(xsd:string)
dcterms:
issued
2019
(xsd:gYear)
swrc:
journal
<
https://dblp.l3s.de/d2r/resource/journals/bmcbi
>
rdfs:
label
Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA.
(xsd:string)
foaf:
maker
<
https://dblp.l3s.de/d2r/resource/authors/Anna_Zhao-Wong
>
foaf:
maker
<
https://dblp.l3s.de/d2r/resource/authors/Darshan_Mehta
>
foaf:
maker
<
https://dblp.l3s.de/d2r/resource/authors/Guangxu_Zhou
>
foaf:
maker
<
https://dblp.l3s.de/d2r/resource/authors/Hong_Fang
>
foaf:
maker
<
https://dblp.l3s.de/d2r/resource/authors/Joshua_Xu
>
foaf:
maker
<
https://dblp.l3s.de/d2r/resource/authors/Junshuang_Yang
>
foaf:
maker
<
https://dblp.l3s.de/d2r/resource/authors/Leihong_Wu
>
foaf:
maker
<
https://dblp.l3s.de/d2r/resource/authors/Shraddha_Thakkar
>
foaf:
maker
<
https://dblp.l3s.de/d2r/resource/authors/Stephen_C._Harris
>
foaf:
maker
<
https://dblp.l3s.de/d2r/resource/authors/Taylor_Ingle
>
foaf:
maker
<
https://dblp.l3s.de/d2r/resource/authors/Weida_Tong
>
foaf:
maker
<
https://dblp.l3s.de/d2r/resource/authors/Weigong_Ge
>
foaf:
maker
<
https://dblp.l3s.de/d2r/resource/authors/Zhichao_Liu
>
swrc:
number
2
(xsd:string)
swrc:
pages
129-139
(xsd:string)
owl:
sameAs
<
http://bibsonomy.org/uri/bibtexkey/journals/bmcbi/WuILZHTZYXMGTF19/dblp
>
owl:
sameAs
<
http://dblp.rkbexplorer.com/id/journals/bmcbi/WuILZHTZYXMGTF19
>
rdfs:
seeAlso
<
http://dblp.uni-trier.de/db/journals/bmcbi/bmcbi20S.html#WuILZHTZYXMGTF19
>
rdfs:
seeAlso
<
https://doi.org/10.1186/s12859-019-2628-5
>
dc:
title
Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA.
(xsd:string)
dc:
type
<
http://purl.org/dc/dcmitype/Text
>
rdf:
type
swrc:Article
rdf:
type
foaf:Document
swrc:
volume
20-S
(xsd:string)